SAN FRANCISCO and SUZHOU, China, May 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that ...

GLORY-3 is a multicenter, randomized, open-label Phase 3 clinical study (NCT06884293) comparing the efficacy and safety of mazdutide versus semaglutide in Chinese adults with overweight or obesity ...

Eli Lilly already posted preliminary data showing its obesity drug, Zepbound topped Novo Nordisk’s Wegovy on measures of weight loss in a head-to-head clinical trial. More detailed results ...

Today’s update for Diablo 4 is a smaller one, primarily focused on bug fixes and balance adjustments. That said, it’s still a pretty lengthy list of patch notes. The update features a host of ...

Blizzard has made something of a surprise announcement: the developer is almost ready to talk about Diablo 4’s next season ... The patch 2.3.0 PTR (Public Test Realm) is close enough, it ...

In Diablo 4, acquiring powerful Unique gear can ... Watch out during his final phase, where he summons multiple Knights Penitents — bring abilities that break crowd control to survive.

For those wondering, this article takes a look at the upcoming Honkai Star Rail 3.3 first phase events. As usual, the developers, HoYoverse, will release a new Trailblaze Mission for all players.

In YouTuber SlimX's accounting of Baldur's Gate 3's behind-the-scenes secrets ... I'm reminded of Diablo 2's legendary Cow Level, which requires you to combine a dead NPC's peg leg with a town ...

AMPLIFY is a study of 64 Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants with Biochemical Recurrence of Prostate Cancer. It is a non-randomised, single-arm ...

The Dying Light The Beast launch is set for summer, as Techland’s zombie spin off arrives free for Dying Light 2 Ultimate Edition owners.